Latest News

STAT Plus: Pharmalittle: Trump and senators push for drug prices in TV ads; Sanofi looks to spin off consumer business

Top of the morning to you, and a fine one it is. We may have returned from a sojourn abroad, but we are enjoying another busy day, thanks to the first ever #STATSummit taking place today in Cambridge (Massachusetts, not England). All sorts of interesting people and topics are on hand, so take a peek if you are unable to join us. Of course, we also look forward to the cups of stimulation being served. Meanwhile, we are pleased to provide the latest menu of tidbits. Have a smashing day and do keep in touch.

President Trump and senators from both parties are still hoping to force drug makers to disclose list prices in TV ads, The Hill reports. The disclosure rule was one of Trump’s highest-profile initiatives and the first policy released after the administration unveiled its drug pricing “blueprint” in 2018. But in July, a federal judge sided with a coalition of three drug makers and advertisers and blocked the Trump administration from implementing the policy.

Continue to STAT Plus to read the full story…



Source link




Related posts

JenaValve launches feasibility study of next-gen pericardial TAVR system

Newsemia

Researchers Design Rapid Method to Custom Build Drug Ferrying Particles

Newsemia

For the first time, U.S. panel recommends screening adults for illicit drug use

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy